(Q46793483)

25 December 2017

title

Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis (English)

1 reference

25 December 2017

0 references

0 references

2

Takao Koike

1 reference

25 December 2017

Eizo Saito

1

1 reference

25 December 2017

Hiroshi Hashimoto

3

1 reference

25 December 2017

Nobuyuki Miyasaka

4

1 reference

25 December 2017

Yasuo Ikeda

5

1 reference

25 December 2017

Masako Hara

6

1 reference

25 December 2017

Hidehiro Yamada

7

1 reference

25 December 2017

Tadashi Yoshida

8

1 reference

25 December 2017

Masayoshi Harigai

9

1 reference

25 December 2017

Yoichi Ichikawa

10

1 reference

25 December 2017

publication date

25 January 2008

1 reference

25 December 2017

published in

Modern Rheumatology

1 reference

25 December 2017

volume

18

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

34-44

1 reference

25 December 2017

Recognition and Management of Myositis

cites work

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0013-0

Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0013-0

High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0013-0

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0013-0

Polymyositis and dermatomyositis (first of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0013-0

Effect of high-dose intravenous immunoglobulin therapy on blood rheology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0013-0

Reversible and irreversible loss of Fc receptor function of human monocytes as a consequence of interaction with immunoglobulin G.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0013-0

Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0013-0

Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0013-0

10.3109/S10165-007-0013-0

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017